CN101757100B - Basil seed chewable tablets - Google Patents

Basil seed chewable tablets Download PDF

Info

Publication number
CN101757100B
CN101757100B CN200910230083.2A CN200910230083A CN101757100B CN 101757100 B CN101757100 B CN 101757100B CN 200910230083 A CN200910230083 A CN 200910230083A CN 101757100 B CN101757100 B CN 101757100B
Authority
CN
China
Prior art keywords
ocimi pilosi
chewable tablets
basil seed
water
fine powder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN200910230083.2A
Other languages
Chinese (zh)
Other versions
CN101757100A (en
Inventor
秦大伟
张娟
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Qilu University of Technology
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN200910230083.2A priority Critical patent/CN101757100B/en
Publication of CN101757100A publication Critical patent/CN101757100A/en
Application granted granted Critical
Publication of CN101757100B publication Critical patent/CN101757100B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention belongs to the technical field of medicament, and discloses chewable tablets taking basil seed as main raw materials. Various auxiliary materials and flavouring agents are added to improve medicament taste while ensuring efficacy; and moreover, the additives are edible and harmless to human body. The adopted special basil seed purification method and conventional processing and tablet-making process ensure low production cost and high yield, and can be widely applied in the medicament field. The obtained basil seed chewable tablets have the advantages of good taste, convenient administration, quick absorption and response, and high bioavailability, and good application prospects.

Description

A kind of basil seed chewable tablets
Technical field:
The present invention relates to a kind of chewable tablet taking Fructus Ocimi Pilosi as primary raw material and preparation method thereof, belong to medical technical field.
Background technology:
Fructus Ocimi Pilosi is Labiatae, Ocimum, and annual armaticity suffruticose herbaceous plant, originates in India, has another name called FRUCTUS OCIMI or Lan Xiangzi, and commercial popular name claims pollen, little Folium Perillae, pearl fruit, jewel fruit.All come from tight drought area short of rain with Caulis et Folium Hyptidis suaveolentis (SHANFEN circle), approximately 30 times of physical characteristics from volume expansion after the water suction of seed nature evolution evolution tool, store moisture content, increase the germination probability of seed.Its size, as Semen Sesami, is soaked in the rapid imbibition of meeting in boiled water, after absorption human body, can promote intestinal peristalsis promoting, contributes to digestion.Because Herba Ocimi (Herba Ocimi Pilosi) kind expands under one's belt, therefore eliminate hunger sensation, also can reach the object of controlling excessive diet.
Record according to Compendium of Material Medica: Fructus Ocimi Pilosi has improving eyesight, protects kidney, the function of diuresis, elimination constipation and body-building health, and has obvious cosmetic slimming effect.It is rich in various mineral, VB 1, VB 2, carotene, abundant machine acid, saccharide and vitamin B group etc.
But existing Fructus Ocimi Pilosi has all adopted the form of direct administration, wherein effective medicinal components utilization rate is low, cannot reach the medicinal object of expection, and due to the taste of medicine self, make user very inconvenient in use, also be not easy to swallowing of patient, in order to develop the medicine resource of Fructus Ocimi Pilosi, be badly in need of a kind of mode that it effectively can be utilized.
Summary of the invention:
For the upper weak point existing of existing Fructus Ocimi Pilosi exploitation, the invention provides a kind of basil seed chewable tablets and adopt the mode of tabletting to prepare chewable tablet, main is that raw material is made chewable tablet with Fructus Ocimi Pilosi extract, be aided with various adjuvants and correctives, in ensureing drug effect, improve the mouthfeel of medicine, and various additives are edible, harmless.The special Fructus Ocimi Pilosi method of purification and the conventional machining film-making technique that adopt, make production cost low, productive rate is high, can be widely used in field of medicaments, it is good that gained basil seed chewable tablets has mouthfeel, taking convenience, absorb rapidly, the advantage rapid-action, bioavailability is high, has good application prospect.
Basil seed chewable tablets of the present invention is made up of Fructus Ocimi Pilosi, and its raw material components is as follows, and each amounts of components is weight portion:
Fructus Ocimi Pilosi fine powder 50-160 part
Filler 750-950 part
Correctives 1-5 part
Water 5-20 part
Lubricant 1-5 part
Wherein selected Fructus Ocimi Pilosi fine powder extracts as follows:
Get Fructus Ocimi Pilosi coarse powder, add 95% ethanol of 8-10 times of weight, 70-90 DEG C of water-bath reflux, extract, three times, each 2-3h, merges three times filtrate, and concentrating under reduced pressure recovery solvent, is concentrated into 5-8% volume, obtains extract; Add a small amount of water and make extract suspendible, through AB-8 macroporous adsorbent resin column chromatography, with water elution, eluent discards; With 95% (w) ethanol elution, collect eluent again, concentrating under reduced pressure reclaims solvent, is concentrated into 1-3% volume, obtains extractum; Gained extractum, in vacuum 55-60 DEG C of dry 20-24 hour, is obtained to drying solid, be ground into powder, obtain Fructus Ocimi Pilosi fine powder.
Adopt this purifying technique the impurity in Fructus Ocimi Pilosi coarse powder can be extracted, and the efficiency of extracting is high, can further improve the active drug composition in residue Fructus Ocimi Pilosi fine powder, and the solvent adopting can not affect the drug effect of Fructus Ocimi Pilosi, ensure its application pharmaceutically.
The adjuvant adopting mainly comprises: filler used is selected from one or more mixture of microcrystalline Cellulose or sucrose or mannitol or dextrin; Correctives used is selected from acesulfame potassium or A Siba is sweet or protein sugar in one or more mixture; With lubricator be selected from one or more mixture in micropowder silica gel or magnesium stearate or Pulvis Talci
Select above-mentioned various adjuvants, can effectively improve the mouthfeel of gained chewable tablet, prevent due to Fructus Ocimi Pilosi self taste cause patient be difficult to take, various adjuvants is mixed simultaneously, can be for follow-up manufacturing procedure provides better preparation, make the chewable tablet of final gained have better basis on being shaped.
The method of preparing this chewable tablet is as follows: the Fructus Ocimi Pilosi coarse powder of getting formula ratio; filler; correctives; spraying adds water; mix homogeneously, sends into granule mechanism granule, at 30~80 DEG C, granule is dried; in dried particles, add lubricant, after mixing, send into tablet machine and make in flakes basil seed chewable tablets.
Adopt this preparation technology can make the chewable tablet that meets pharmaceutical standards, and be all conventional preparation method and equipment due to what adopt, can adopt existing equipment directly to produce, save production cost, facilitate large-area promotion and application simultaneously, ensured its application pharmaceutically.
It is good that gained basil seed chewable tablets of the present invention has mouthfeel, and taking convenience absorbs rapidly, and rapid-action, the advantage that bioavailability is high, has good application prospect; The special Fructus Ocimi Pilosi method of purification and the conventional machining film-making technique that adopt, make production cost low, and productive rate is high, can be widely used in field of medicaments,
Detailed description of the invention:
Understand technical scheme of the present invention for better, below describe in further detail by specific embodiment.
Embodiment 1:
Get Fructus Ocimi Pilosi coarse powder 2kg, add 18kg95% ethanol, 80 DEG C of water-bath reflux, extract, three times, each 2.5h, merges three times filtrate, and concentrating under reduced pressure recovery solvent, is concentrated into 7% volume, obtains extract; Add a small amount of water and make extract suspendible, through AB-8 macroporous adsorbent resin column chromatography, with water elution, eluent discards; With 95% (w) ethanol, collect eluent again, concentrating under reduced pressure reclaims solvent, is concentrated into 2% volume, obtains extractum; Gained extractum is dried to 24 hours in 60 DEG C, vacuum, obtains drying solid, be ground into powder, obtain Fructus Ocimi Pilosi fine powder.
Get the above-mentioned Fructus Ocimi Pilosi fine powder of 100g, 800g microcrystalline Cellulose, 4g acesulfame potassium; spraying adds 15g water, and mix homogeneously is sent into granule mechanism granule; at 60 DEG C, granule is dried, in dried particles, adds 3g micropowder silica gel, mix and send into tablet machine and make in flakes basil seed chewable tablets.
Embodiment 2:
Get Fructus Ocimi Pilosi coarse powder 2kg, add 18kg 95% ethanol, 80 DEG C of water-bath reflux, extract, three times, each 2.5h, merges three times filtrate, and concentrating under reduced pressure recovery solvent, is concentrated into 7% volume, obtains extract; Add a small amount of water and make extract suspendible, through AB-8 macroporous adsorbent resin column chromatography, with water elution, eluent discards; Wash so that 95% (w) ethanol is de-, collect eluent, concentrating under reduced pressure reclaims solvent, is concentrated into 2% volume, obtains extractum; Gained extractum is dried to 24 hours in 60 DEG C, vacuum, obtains drying solid, be ground into powder, obtain Fructus Ocimi Pilosi fine powder.
Get the above-mentioned Fructus Ocimi Pilosi fine powder of 100g, 800g sucrose, 4g A Siba is sweet; spraying adds 15g water, and mix homogeneously is sent into granule mechanism granule; at 60 DEG C, granule is dried, in dried particles, adds 3g magnesium stearate, mix and send into tablet machine and make in flakes basil seed chewable tablets.
Embodiment 3:
Get Fructus Ocimi Pilosi coarse powder 2kg, add 18kg 95% ethanol, 80 DEG C of water-bath reflux, extract, three times, each 2.5h, merges three times filtrate, and concentrating under reduced pressure recovery solvent, is concentrated into 7% volume, obtains extract; Add a small amount of water and make extract suspendible, through AB-8 macroporous adsorbent resin column chromatography, with water elution, eluent discards; With 95% (w) ethanol elution, collect eluent again, concentrating under reduced pressure reclaims solvent, is concentrated into 2% volume, obtains extractum; Gained extractum is dried to 24 hours in 60 DEG C, vacuum, obtains drying solid, be ground into powder, obtain Fructus Ocimi Pilosi fine powder.
Get the above-mentioned Fructus Ocimi Pilosi fine powder of 100g, 800g mannitol, 4g protein sugar; spraying adds 15g water, and mix homogeneously is sent into granule mechanism granule; at 60 DEG C, granule is dried, in dried particles, adds 3g Pulvis Talci, mix and send into tablet machine and make in flakes basil seed chewable tablets.

Claims (2)

1. a basil seed chewable tablets, is characterized in that: the active component adopting is Fructus Ocimi Pilosi fine powder, is aided with other pharmaceutic adjuvant, and its raw material components is as follows, and each amounts of components is weight portion:
Wherein selected Fructus Ocimi Pilosi fine powder extracts as follows:
Get Fructus Ocimi Pilosi coarse powder, add 95% ethanol of 8-10 times of weight, 70-90 DEG C of water-bath reflux, extract, three times, each 2-3h, merges three times filtrate, and concentrating under reduced pressure recovery solvent, is concentrated into 5-8% volume, obtains extract; Add a small amount of water and make extract suspendible, through AB-8 macroporous adsorbent resin column chromatography, with water elution, eluent discards; With percentage by weight 95% ethanol elution, collect eluent again, concentrating under reduced pressure reclaims solvent, is concentrated into 1-3% volume, obtains extractum; Gained extractum, in vacuum 55-60 DEG C of dry 20-24 hour, is obtained to drying solid, be ground into powder, obtain Fructus Ocimi Pilosi fine powder;
Wherein said filler is selected from one or more mixture of microcrystalline Cellulose or sucrose or mannitol or dextrin;
Described correctives is selected from acesulfame potassium or A Siba one or more the mixture in sweet;
Described lubricant is selected from one or more the mixture in micropowder silica gel or magnesium stearate or Pulvis Talci.
2. the method for preparation basil seed chewable tablets as claimed in claim 1; it is characterized in that: its preparation method is as follows: the Herba Ocimi (Herba Ocimi Pilosi) of getting formula ratio gives fine powder; filler; correctives, spraying adds water, mix homogeneously; send into granule mechanism granule; at 30~80 DEG C, granule is dried, in dried particles, adds lubricant, after mixing, send into tablet machine and make in flakes basil seed chewable tablets.
CN200910230083.2A 2009-11-13 2009-11-13 Basil seed chewable tablets Expired - Fee Related CN101757100B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN200910230083.2A CN101757100B (en) 2009-11-13 2009-11-13 Basil seed chewable tablets

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN200910230083.2A CN101757100B (en) 2009-11-13 2009-11-13 Basil seed chewable tablets

Publications (2)

Publication Number Publication Date
CN101757100A CN101757100A (en) 2010-06-30
CN101757100B true CN101757100B (en) 2014-12-10

Family

ID=42488582

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200910230083.2A Expired - Fee Related CN101757100B (en) 2009-11-13 2009-11-13 Basil seed chewable tablets

Country Status (1)

Country Link
CN (1) CN101757100B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104643090B (en) * 2015-03-24 2016-11-30 吉林工商学院 A kind of containing the Folium Perillae dregs of rice, Herba Ocimi (Herba Ocimi Pilosi) seed and the manufacture method of Abelmoschus esculentus slimming capsule

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101444245A (en) * 2007-11-26 2009-06-03 天津市金圭谷木糖醇有限公司 Mulberry leaf chewing tablet with sugar-lowering function

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101444245A (en) * 2007-11-26 2009-06-03 天津市金圭谷木糖醇有限公司 Mulberry leaf chewing tablet with sugar-lowering function

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
《咀嚼片的研究进展》;施昕磊等;《中国药业》;20081231;第17卷(第14期);17-18 *
施昕磊等.《咀嚼片的研究进展》.《中国药业》.2008,第17卷(第14期),17-18. *

Also Published As

Publication number Publication date
CN101757100A (en) 2010-06-30

Similar Documents

Publication Publication Date Title
CN103446450B (en) A kind of composition and method of making the same with alleviating physical fatigue function
CN104274537A (en) Traditional Chinese medicine composition, and preparation method and application thereof
CN101229236A (en) Relieve asthma oral liquid preparation and preparing method thereof
CN101757057B (en) Whiteflower leadword root chewable tablet
CN104382993A (en) Compound liquorice tablet and preparation process thereof
CN101229325A (en) Rhizoma gastrodiae chewable tablet and preparing method thereof
CN101757100B (en) Basil seed chewable tablets
CN102727556A (en) Throat-clearing traditional Chinese medicine buccal tablet and preparation method thereof
CN101757074B (en) Chewable tablet prepared from berberis
CN103520456A (en) Compound traditional Chinese medicinal granules for treating common cold and cough
CN103169815A (en) Radix tetrastigme lozenge and preparation method thereof
CN1927279A (en) Chinese medicine composition for treating skin disease
CN101732555A (en) Medicament for treating cold cough and chronic bronchitis
CN1985946A (en) New preparing process for lung heat clearing and phlegm resolving preparation
CN1969973A (en) Chinese medicinal soft capsule for treating stomachache
CN102120016B (en) Method for preparing Sichuan fritillary bulb and fructus momordicae cough relieving tablets
CN104958342A (en) Lonicera japonica leaf flavonoid capsule
CN101757475A (en) Method for preparing fresh snow preparation
CN102119996A (en) Preparation method of sugarless fritillaria cirrhosa-fructus momordicae granules for relieving cough
CN101780127A (en) Ajowan-caraway seedchewable tablet and preparation method thereof
CN101269123A (en) Secondary development novel technique for thirst eliminating capsule for lowering blood sugar
CN101919919A (en) Fukean dispersible tablet and preparation method thereof
CN1785245A (en) Method for preparing composite traditional Chinese medicine soft capsule
CN104257990B (en) Smilacina japonica buccal tablet and preparation method thereof
CN103705832A (en) Astragalus chewable tablets and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: QILU UNIVERSITY OF TECHNOLOGY

Free format text: FORMER OWNER: QIN DAWEI

Effective date: 20141127

C41 Transfer of patent application or patent right or utility model
C53 Correction of patent for invention or patent application
CB03 Change of inventor or designer information

Inventor after: Qin Dawei

Inventor after: Li Lei

Inventor after: Zhang Yongchun

Inventor after: Zhang Juan

Inventor before: Qin Dawei

Inventor before: Zhang Juan

COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 250022 JINAN, SHANDONG PROVINCE TO: 250353 JINAN, SHANDONG PROVINCE

Free format text: CORRECT: INVENTOR; FROM: QIN DAWEI ZHANG JUAN TO: QIN DAWEI LI LEI ZHANG YONGCHUN ZHANG JUAN

TR01 Transfer of patent right

Effective date of registration: 20141127

Address after: 250353 Ji'nan University, Changqing, Shandong Road, No. 3501

Patentee after: Qilu University of Technology

Address before: Nanxinzhuang street in Huaiyin District of Ji'nan city of Shandong Province, No. 70 250022

Patentee before: Qin Dawei

CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20141210

Termination date: 20151113

EXPY Termination of patent right or utility model